OTTplay Logo
settings icon
profile icon

Box Office advance booking updates: Shah Rukh Khan’s Pathaan vs. Ant-Man and the Wasp: Quantumania vs. Kartik Aaryan’s Shehzada

While Pathaan is still going strong, Ant-Man 3 appears to be the undisputed winner, and Shezada will need to pick up the slack at the box office. 

Box Office advance booking updates: Shah Rukh Khan’s Pathaan vs. Ant-Man and the Wasp: Quantumania vs. Kartik Aaryan’s Shehzada
BO Update: Pathaan vs Antman vs Shehzada

Last Updated: 05.42 PM, Feb 17, 2023

Share

Shah Rukh Khan's action extravaganza cannot enjoy a solo show because there are now two strong contenders for the top spot. Well, one could say that Kartik Aaryan still comes off as lethargic compared to the speed set by Paul Rudd's Marvel film. 

Post Bhool Bhulaiyaa 2, Shehzada is only expected to get better and bigger, although a lot of its current success depends on word-of-mouth and advance reservations. Shah Rukh Khan's movie has now been in theatres for three weeks, but it continues to do well. Marvel’s Ant-Man And The Wasp: Quantumania, on the other hand, is set for a huge opening and the pre-buzz is massive.

According to trade expert Taran Adarsh, Ant-Man 3 has a significant lead in this box office competition. Over 1.06 lakh tickets for the Paul Rudd movie have been sold at national chains. Shehzada, produced by Kartik Aaryan, is in second place with nearly 25,000 tickets sold, although the pace is not as fast as it is for Pathaan, which has sold 17,400 tickets in advance for today.

It should be mentioned that Pathaan has already reaped the greatest amount of box office benefits, proving that it is still very good. So far, it looks like the conflict has had little impact on the movie. For Shehzada to acquire traction at the box office, there needs to be a lot of talk surrounding its reviews. The winner here is undoubtedly Ant-Man and the Wasp: Quantumania, but it remains to be seen if the movie will be able to top prior records set by other Marvel movies for opening weekend numbers.

      Get the latest updates in your inbox
      Subscribe